| Patent Number |
Title Of Patent |
Date Issued |
| 6887849 |
Long lasting synthetic glucagon-like peptide {GLP-1} |
May 3, 2005 |
| Modified insulinotropic peptides are disclosed. The modified insulinotropic peptides are capable of forming a peptidase stabilized insulinotropic peptide. The modified insulinotropic peptides are capable of forming covalent bonds with one or more blood components to form a conjugate. The |
| 6821949 |
Long lasting synthetic glucagon-like peptide (GLP-1) |
November 23, 2004 |
| Modified insulinotropic peptides are disclosed. The modified insulinotropic peptides are capable of forming a peptidase stabilized insulinotropic peptide. The modified insulinotropic peptides are capable of forming covalent bonds with one or more blood components to form a conjugate. The |
| 6593295 |
Long lasting insulinotropic peptides |
July 15, 2003 |
| Modified insulinotropic peptides are disclosed. The modified insulinotropic peptides are capable of forming a peptidase stabilized insulinotropic peptide. The modified insulinotropic peptides are capable of forming covalent bonds with one or more blood components to form a conjugate. The |
| 6514500 |
Long lasting synthetic glucagon like peptide {GLP-!} |
February 4, 2003 |
| Modified insulinotropic peptides are disclosed. The modified insulinotropic peptides are capable of forming a peptidase stabilized insulinotropic peptide. The modified insulinotropic peptides are capable of forming covalent bonds with one or more blood components to form a conjugate. The |
| 6329336 |
Long lasting insulinotropic peptides |
December 11, 2001 |
| Modified insulinotropic peptides are disclosed. The modified insulinotropic peptides are capable of forming a peptidase stabilized insulinotropic peptide. The modified insulinotropic peptides are capable of forming covalent bonds with one or more blood components to form a conjugate. The |
